Cipla Health strengthens its play in beauty and personal care
CHL is strengthening its play in the fast-growing beauty and personal care sector
CHL is strengthening its play in the fast-growing beauty and personal care sector
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The Product is expected to be the first generic approval on the market
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Currently, Sharma is a part of the Philippines Country Leadership Team as Business Unit Head Respiratory & Immunology
Subscribe To Our Newsletter & Stay Updated